7 September 2014
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/jqM10TSQe_k/140907181156.htm
